News

Unlike other pathologies, amyotrophic lateral sclerosis (ALS) cannot be reproduced accurately in animal models, complicating ...
Bioengineers at Queen Mary University of London have taken a significant step forward in the development of laboratory-based ...
Organoids Market is Segmented by Type (Stem Cell Source, Tumor Cell Source), by Application (Biopharmaceutical Companies, Academics and Research Institutes, Hospital).
Sheffield leads a lab at the UChicago Neuroscience Institute, where he and other researchers are working to better understand ...
This Research Topic is proposed in collaboration with the 5th edition of the JRC Summer School on Non-Animal Approaches in ...
Methylene blue is FDA-approved to treat a rare blood disorder, but influencers are touting it as a brain and longevity ...
In research led by the Keck School of Medicine of USC, the new drug candidate selectively attacked glioblastoma stem cells and passed early safety testing in a phase 1 clinical trial.
Q1 2025 Earnings Call Transcript May 12, 2025 Harvard Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.01, ...
In a comprehensive Genomic Psychiatry review article published today, researchers from the University of Rochester Medical ...
Ten years ago, quinoa was virtually unheard of outside South America. Now, the staple food of the Andes is found everywhere ...